Zhang; Geoff G. Z.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Zhang; Geoff G. Z..The latest application filed is for "salt and crystalline forms thereof of a drug".
Company Profile
1.53.63
- Zhang; Geoff G. Z. - Libertyville IL
- Zhang; Geoff G. Z. - Vernon Hills IL US
Patent Activity
| Patent | Date |
|---|---|
| Salt and crystalline forms thereof of a drug Grant 10,329,276 - Zhang , et al. | 2019-06-25 |
| Salt And Crystalline Forms Thereof Of A Drug App 20180105510 - ZHANG; Geoff G.Z. ; et al. | 2018-04-19 |
| Salt and crystalline forms thereof of a drug Grant 9,873,681 - Zhang , et al. January 23, 2 | 2018-01-23 |
| Salt And Crystalline Forms Thereof Of A Drug App 20170073329 - ZHANG; Geoff G.Z. ; et al. | 2017-03-16 |
| Salt and crystalline forms thereof of a drug Grant 9,539,250 - Zhang , et al. January 10, 2 | 2017-01-10 |
| Monohydrate of azaadamantane derivatives Grant 9,464,078 - Chen , et al. October 11, 2 | 2016-10-11 |
| Crystalline Form Of A Drug App 20150266860 - ZHANG; Geoff G.Z. | 2015-09-24 |
| Anti-infective agents and uses thereof Grant 9,139,536 - Flentge , et al. September 22, 2 | 2015-09-22 |
| Novel Monohydrate Of Azaadamantane Derivatives App 20150239882 - Chen; Shuang ; et al. | 2015-08-27 |
| Salt and Crystalline Forms Thereof of a Drug App 20150196547 - ZHANG; Geoff G.Z. ; et al. | 2015-07-16 |
| Azaadamantane Derivatives And Methods Of Use App 20150158867 - Schrimpf; Michael R. ; et al. | 2015-06-11 |
| Crystalline form of a drug Grant 9,051,301 - Zhang June 9, 2 | 2015-06-09 |
| Preparation of Pyridonecarboxylic Acid Antibacterials App 20150094475 - HAIGHT; Anthony ; et al. | 2015-04-02 |
| Anti-infective agents and uses thereof Grant 8,986,740 - Donner , et al. March 24, 2 | 2015-03-24 |
| Azaadamantane derivatives and methods of use Grant 8,987,453 - Schrimpf , et al. March 24, 2 | 2015-03-24 |
| Salt and crystalline forms thereof of a drug Grant 8,969,569 - Zhang , et al. March 3, 2 | 2015-03-03 |
| Pharmaceutical Composition Having Improved Dissolution Profiles For Poorly Soluble Drugs App 20150057266 - WU; Huailiang ; et al. | 2015-02-26 |
| Preparation of pyridonecarboxylic acid antibacterials Grant 8,927,723 - Haight , et al. January 6, 2 | 2015-01-06 |
| ABT-263 capsule Grant 8,927,009 - Tong , et al. January 6, 2 | 2015-01-06 |
| Anti-Infective Agents and Uses Thereof App 20140294766 - Flentge; Charles A. ; et al. | 2014-10-02 |
| Salts Of Fenofibric Acid And Pharmaceutical Formulations Thereof App 20140187561 - Cink; Russell Drew ; et al. | 2014-07-03 |
| Preparation Of Pyridonecarboxylic Acid Antibacterials App 20140155610 - HAIGHT; Anthony ; et al. | 2014-06-05 |
| Salt and Crystalline Forms Thereof of a Drug App 20140155380 - ZHANG; Geoff G.Z. ; et al. | 2014-06-05 |
| Stabilized lipid formulation of apoptosis promoter Grant 8,728,516 - Catron , et al. May 20, 2 | 2014-05-20 |
| Preparation of pyridonecarboxylic acid antibacterials Grant 8,648,196 - Haight , et al. February 11, 2 | 2014-02-11 |
| Salt and crystalline forms thereof of a drug Grant 8,648,093 - Zhang , et al. February 11, 2 | 2014-02-11 |
| Crystal forms of kinase inhibitors Grant 8,633,217 - Zhang , et al. January 21, 2 | 2014-01-21 |
| Crystalline salts of thieno[3,2-c]pyridine kinase inhibitors with improved cpy safety profile Grant 8,633,317 - Zhang , et al. January 21, 2 | 2014-01-21 |
| Methods of treating cancer with a thieno[3,2-C]pyridine Grant 8,592,589 - Zhang , et al. November 26, 2 | 2013-11-26 |
| ABT-263 crystalline forms Grant 8,513,243 - Zhang , et al. August 20, 2 | 2013-08-20 |
| Anti-infective agents and uses thereof Grant 8,501,238 - Flentge , et al. August 6, 2 | 2013-08-06 |
| Solid Compositions App 20130172239 - Gao; Yi ; et al. | 2013-07-04 |
| Crystal Forms of Kinase Inhibitors App 20130136804 - Zhang; Geoff G.Z. ; et al. | 2013-05-30 |
| Azaadamantane Derivatives And Methods Of Use App 20130096132 - Schrimpf; Michael R. ; et al. | 2013-04-18 |
| Preparation of Pyridonecarboxylic Acid Antibacterials App 20130085281 - HAIGHT; Anthony ; et al. | 2013-04-04 |
| Octahydro-pyrrolo[3,4-B]pyrrole derivatives Grant 8,399,468 - Cowart , et al. March 19, 2 | 2013-03-19 |
| Salt and Crystalline Forms Thereof of a Drug App 20130060040 - Zhang; Geoff G.Z. ; et al. | 2013-03-07 |
| Salt of ABT-263 and solid-state forms thereof Grant 8,362,013 - Borchardt , et al. January 29, 2 | 2013-01-29 |
| ABT-263 crystalline forms Grant 8,362,014 - Zhang , et al. January 29, 2 | 2013-01-29 |
| Crystal forms of kinase inhibitors Grant 8,357,804 - Zhang , et al. January 22, 2 | 2013-01-22 |
| Salts Of Fenofibric Acid And Pharmaceutical Formulations Thereof App 20130018101 - Cink; Russell Drew ; et al. | 2013-01-17 |
| Pharmaceutical Compositions Having Improved Dissolution Profiles For Poorly Soluble Drugs App 20120309740 - WU; Huailiang ; et al. | 2012-12-06 |
| Azaadamantane derivatives and methods of use Grant 8,314,119 - Schrimpf , et al. November 20, 2 | 2012-11-20 |
| Preparation of pyridonecarboxylic acid antibacterials Grant 8,299,254 - Haight , et al. October 30, 2 | 2012-10-30 |
| Anti-infective Agents And Uses Thereof App 20120244119 - Flentge; Charles A. ; et al. | 2012-09-27 |
| Novel Monohydrate Of Azaadamantane Derivatives App 20120245195 - Chen; Shuang ; et al. | 2012-09-27 |
| Salt and crystalline forms thereof of a drug Grant 8,273,892 - Zhang , et al. September 25, 2 | 2012-09-25 |
| Salt and crystalline forms thereof of a drug Grant 8,252,813 - Zhang , et al. August 28, 2 | 2012-08-28 |
| Crystalline Forms of Kinase Inhibitors App 20120203002 - Zhang; Geoff G. Z. ; et al. | 2012-08-09 |
| Crystal Forms of Kinase Inhibitors App 20120202844 - Zhang; Geoff G. Z. ; et al. | 2012-08-09 |
| Anti-infective Agents And Uses Thereof App 20120189580 - Donner; Pamela L. ; et al. | 2012-07-26 |
| Crystal Forms of Kinase Inhibitors App 20120149726 - Zhang; Geoff G. Z. ; et al. | 2012-06-14 |
| Anti-infective agents and uses thereof Grant 8,188,104 - Flengte , et al. May 29, 2 | 2012-05-29 |
| Anti-infective agents and uses thereof Grant 8,178,548 - Donner , et al. May 15, 2 | 2012-05-15 |
| Abt-263 Crystalline Forms App 20110294811 - Zhang; Geoff G. Z. ; et al. | 2011-12-01 |
| Abt-263 Capsule App 20110159085 - Tong; Ping ; et al. | 2011-06-30 |
| Abt-263 Crystalline Forms App 20110071151 - Zhang; Geoff G.Z. ; et al. | 2011-03-24 |
| (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate Grant 7,902,371 - Wayne , et al. March 8, 2 | 2011-03-08 |
| Pharmaceutical Compositions Having Improved Dissolution Profiles For Poorly Soluble Drugs App 20100324018 - Wu; Huailiang ; et al. | 2010-12-23 |
| Salt Of Abt-263 And Solid-state Forms Thereof App 20100305125 - Borchardt; Thomas ; et al. | 2010-12-02 |
| Formulation For Oral Administration Of Apoptosis Promoter App 20100297194 - Catron; Nathaniel ; et al. | 2010-11-25 |
| Salt And Crystalline Forms Thereof Of A Drug App 20100286397 - Zhang; Geoff G.Z. ; et al. | 2010-11-11 |
| Stabilized Lipid Formulation Of Apoptosis Promoter App 20100278905 - Catron; Nathaniel ; et al. | 2010-11-04 |
| Salt And Crystalline Forms Thereof Of A Drug App 20100261703 - Zhang; Geoff G.Z. ; et al. | 2010-10-14 |
| Octahydro-pyrrolo[3,4-b]pyrrole Derivatives App 20100222358 - Cowart; Marlon D. ; et al. | 2010-09-02 |
| Salt and crystalline forms thereof of a drug Grant 7,728,143 - Zhang , et al. June 1, 2 | 2010-06-01 |
| Preparation Of Pyridonecarboxylic Acid Antibacterials App 20100041890 - Haight; Anthony ; et al. | 2010-02-18 |
| Salts Of Fenofibric Acid And Pharmaceutical Formulations Thereof App 20090263477 - Cink; Russell D. ; et al. | 2009-10-22 |
| Preparation of pyridonecarboxylic acid antibacterials Grant 7,576,216 - Haight , et al. August 18, 2 | 2009-08-18 |
| (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6- Diazabicyclo[3.2.0]heptane App 20090203664 - Buckley; Michael J. ; et al. | 2009-08-13 |
| (1S,5S)-3-(5,6-Dichloropyridin-3-YL)-3,6-Diazabicyclo[3.2.0]Heptane Benzenesulfonate App 20090198067 - Wayne; Gregory S. ; et al. | 2009-08-06 |
| Anti-infective Agents And Uses Thereof App 20090186912 - Flengte; Charles A. ; et al. | 2009-07-23 |
| Anti-infective Agents And Uses Thereof App 20090176784 - Donner; Pamela L. ; et al. | 2009-07-09 |
| (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane Grant 7,538,226 - Buckley , et al. May 26, 2 | 2009-05-26 |
| (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate Grant 7,498,444 - Wayne , et al. March 3, 2 | 2009-03-03 |
| N-(2((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide Crystalline Form 1 Grant 7,449,584 - Schmitt , et al. November 11, 2 | 2008-11-11 |
| N-((2Z)-2-((4-hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2 Grant 7,446,206 - Schmitt , et al. November 4, 2 | 2008-11-04 |
| Azaadamantane Derivatives And Methods Of Use App 20080167336 - Schrimpf; Michael R. ; et al. | 2008-07-10 |
| Atrasentan Hydrochloride Crystalline Form 2 App 20080132710 - Henry; Rodger F. ; et al. | 2008-06-05 |
| (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane Grant 7,354,937 - Buckley , et al. April 8, 2 | 2008-04-08 |
| (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate Grant 7,351,833 - Wayne , et al. April 1, 2 | 2008-04-01 |
| (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane App 20080070891 - Buckley; Michael J. ; et al. | 2008-03-20 |
| Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof App 20080051411 - Cink; Russell Drew ; et al. | 2008-02-28 |
| (1s,5s)-3-(5.6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane Benzenesulfonate App 20080004448 - Wayne; Gregory S. ; et al. | 2008-01-03 |
| Octahydro-pyrrolo[3,4-b]pyrrole Derivatives App 20070232612 - Cowart; Marlon D. ; et al. | 2007-10-04 |
| Salts of fenofibric acid and pharmaceutical formulations thereof Grant 7,259,186 - Cink , et al. August 21, 2 | 2007-08-21 |
| Crystalline form of a drug App 20070123582 - Zhang; Geoff G.Z. | 2007-05-31 |
| Formulation comprising a drug of low water solubility and method of use thereof App 20070104780 - Lipari; John M. ; et al. | 2007-05-10 |
| N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide crystalline form 1 App 20070099967 - Schmitt; Eric A. ; et al. | 2007-05-03 |
| Salt and crystalline forms thereof of a drug App 20070043019 - Zhang; Geoff G.Z. ; et al. | 2007-02-22 |
| Crystalline N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide hydrochloride App 20070004781 - Schmitt; Eric A. ; et al. | 2007-01-04 |
| N-((2Z)-2-((4-Hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide Crystalline Form 2 App 20070004782 - Schmitt; Eric A. ; et al. | 2007-01-04 |
| Amorphous N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfo- namide hydrochloride App 20060293368 - Zhang; Geoff G.Z. | 2006-12-28 |
| Amorphous N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfo- namide App 20060293367 - Zhang; Geoff G.Z. | 2006-12-28 |
| Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs App 20060228411 - Wu; Huailiang ; et al. | 2006-10-12 |
| Amorphous form of a drug App 20060135596 - Zhang; Geoff G.Z. | 2006-06-22 |
| Preparation of pyridonecarboxylic acid antibacterials App 20060128686 - Haight; Anthony ; et al. | 2006-06-15 |
| (1S,5S)-3-(5,6-dichloropyridin-3-YL)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate App 20060035937 - Wayne; Gregory S. ; et al. | 2006-02-16 |
| (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane App 20060035936 - Buckley; Michael J. ; et al. | 2006-02-16 |
| Salts of fenofibric acid and pharmaceutical formulations thereof App 20050148594 - Cink, Russell Drew ; et al. | 2005-07-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 